Dorina Procopciuc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dorina Procopciuc has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adriana-Ionela Patrascu
Discipline of Dermatology-Venereology, Department of Medical Sciences III, Faculty of Medicine “Grigore T. Popa”, University of Medicine and Pharmacy, 700115 Iași, Romania
1 shared publication - Dan Vâță
Department of Dermatology, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Doinița Temelie-Olinici
Department of Morpho-Functional Sciences II, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iași, Romania
1 shared publication - Dragos Florin Gheuca Solovastru
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Ioana Adriana Popescu
Department of Dermatology, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication - Laura Gheucă Solovăstru
Department of Dermatology, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
1 shared publication
Latest Publications
- Open Access
An Overview of Methotrexate Indications in Skin Diseases
Methotrexate is an immunosuppressive drug with remarkable therapeutic results in the treatment of autoimmune and proliferative skin diseases. Although it has been more than half a century since it was first introduced into the therapeutic arsenal of dermatologists, there are currently no standardized therapeutic protocols regarding the prescription of methotrexate in dermatology, with the exception of psoriasis treatment. This review aims to highlight the indications and benefits of methotrexate beyond psoriasis, with a focus on a wide range of inflammatory, vesiculobullous, and proliferative dermatological pathologies.
Open AccessAn Overview of Methotrexate Indications in Skin Diseases
Methotrexate is an immunosuppressive drug with remarkable therapeutic results in the treatment of autoimmune and proliferative skin diseases. Although it has been more than half a century since it was first introduced into the therapeutic arsenal of dermatologists, there are currently no standardized therapeutic protocols regarding the prescription of methotrexate in dermatology, with the exception of psoriasis treatment. This review aims to highlight the indications and benefits of methotrexate beyond psoriasis, with a focus on a wide range of inflammatory, vesiculobullous, and proliferative dermatological pathologies.